EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $685,066 | -64.0% | 35,240 | -47.5% | 0.00% | -60.0% |
Q1 2023 | $1,903,031 | -7.1% | 67,079 | -4.3% | 0.01% | -16.7% |
Q4 2022 | $2,049,345 | -23.7% | 70,111 | -31.0% | 0.01% | -25.0% |
Q3 2022 | $2,685,000 | -54.0% | 101,634 | -22.6% | 0.01% | -50.0% |
Q2 2022 | $5,835,000 | -10.3% | 131,340 | -0.1% | 0.02% | +6.7% |
Q1 2022 | $6,504,000 | -0.9% | 131,413 | +2.0% | 0.02% | +25.0% |
Q4 2021 | $6,563,000 | -8.6% | 128,887 | +0.1% | 0.01% | -14.3% |
Q3 2021 | $7,179,000 | +36.8% | 128,702 | +5.0% | 0.01% | +40.0% |
Q2 2021 | $5,247,000 | -0.9% | 122,590 | -3.4% | 0.01% | 0.0% |
Q1 2021 | $5,295,000 | +26.6% | 126,849 | +41.3% | 0.01% | +11.1% |
Q4 2020 | $4,182,000 | +77.8% | 89,797 | +62.2% | 0.01% | +50.0% |
Q3 2020 | $2,352,000 | +393.1% | 55,371 | +598.1% | 0.01% | +500.0% |
Q4 2019 | $477,000 | -77.2% | 7,932 | -78.6% | 0.00% | -80.0% |
Q3 2019 | $2,096,000 | -61.7% | 37,050 | -62.3% | 0.01% | -61.5% |
Q2 2019 | $5,476,000 | -23.6% | 98,355 | -30.7% | 0.01% | -27.8% |
Q1 2019 | $7,164,000 | +435.0% | 141,891 | +326.8% | 0.02% | +350.0% |
Q4 2018 | $1,339,000 | +191.1% | 33,242 | +281.1% | 0.00% | +300.0% |
Q1 2018 | $460,000 | +11.7% | 8,723 | +87.6% | 0.00% | 0.0% |
Q4 2015 | $412,000 | -30.9% | 4,651 | -42.3% | 0.00% | -50.0% |
Q3 2015 | $596,000 | +59500.0% | 8,056 | +57442.9% | 0.00% | – |
Q2 2015 | $1,000 | – | 14 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |